Meningococcal serogroup B vaccines: Estimating breadth of coverage-Reference-Cited by-同舟云学术

Meningococcal serogroup B vaccines: Estimating breadth of coverage

Published:2016-12-14 Issue:2 Volume:13 Page:255-265
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Donald Robert G. K.¹,Hawkins Julio Cesar¹,Hao Li¹,Liberator Paul¹,Jones Thomas R.¹,Harris Shannon L.¹,Perez John L.²,Eiden Joseph J.¹,Jansen Kathrin U.¹,Anderson Annaliesa S.¹

Affiliation:

1. Pfizer Vaccine Research and Development, Pearl River, NY, USA

2. Pfizer Vaccine Research and Development, Collegeville, PA, USA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2017.1264750

Reference77 articles.

1. Meningococcal Vaccines

2. Meningococcal disease: Clinical presentation and sequelae

3. Description and Nomenclature ofNeisseria meningitidisCapsule Locus

4. Enhanced surveillance of invasive meningococcal disease in Canada, 2006-2011

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Past, present, and future policy considerations regarding meningococcal vaccination in the United States;Expert Review of Vaccines;2024-09-11

2. Bioinformatics Analysis of Global Diversity in Meningococcal Vaccine Antigens over the Past 10 Years: Vaccine Efficacy Prognosis;Medical Sciences;2023-12-01

3. Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022;mBio;2023-04-25

4. Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverage;Expert Review of Vaccines;2022-06-03

5. Structural characterization of a cross-protective natural chimera of factor H binding protein from meningococcal serogroup B strain NL096;Computational and Structural Biotechnology Journal;2022